Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christopher P Cannon

Showing results (641-650 of 706) with videos related to

Pageof 71
Sort By:
Journal of the American College of Cardiology|January 4, 2011
Ticagrelor versus clopidogrel in patients with acute coronary syndromes undergoing coronary artery bypass surgery: results from the PLATO (Platelet Inhibition and Patient Outcomes) trialClaes Held, Nils Asenblad, Jean Pierre Bassand, et al.
European Heart Journal|September 22, 2018
Modes and timing of death in 66 252 patients with non-ST-segment elevation acute coronary syndromes enrolled in 14 TIMI trialsDavid D Berg, Stephen D Wiviott, Eugene Braunwald, et al.
Diabetes Care|September 25, 2019
Diabetes Is Associated With Worse Long-term Outcomes in Young Adults After Myocardial Infarction: The Partners YOUNG-MI RegistrySanjay Divakaran, Avinainder Singh, David Biery, et al.
Circulation|February 15, 2021
Sex, Permanent Drug Discontinuation, and Study Retention in Clinical Trials: Insights From the TIMI trialsEmily S Lau, Eugene Braunwald, David A Morrow, et al.
American Heart Journal|June 2, 2020
In patients with stable coronary heart disease, low-density lipoprotein-cholesterol levels < 70 mg/dL and glycosylated hemoglobin A1c < 7% are associated with lower major cardiovascular eventsHarvey D White, Ralph A H Stewart, Anthony J Dalby, et al.
Journal of the American College of Cardiology|July 7, 2012
An invasive or conservative strategy in patients with diabetes mellitus and non-ST-segment elevation acute coronary syndromes: a collaborative meta-analysis of randomized trialsMichelle L O'Donoghue, Ajay Vaidya, Rizwan Afsal, et al.
The American Journal of Medicine|May 12, 2020
Comparison of Dabigatran Plus a P2Y<sub>12</sub> Inhibitor With Warfarin-Based Triple Therapy Across Body Mass Index in RE-DUAL PCIRaffaele De Caterina, Antonio Procopio, José-Luis Lopez Sendon, et al.
Journal of the American College of Cardiology|October 27, 2022
Cardiovascular Effects of Canagliflozin in Relation to Renal Function and AlbuminuriaAshish Sarraju, George Bakris, Christopher P Cannon, et al.
Circulation|April 7, 2024
Randomized Evaluation of a Remote Management Program to Improve Guideline-Directed Medical Therapy: The DRIVE TrialAlexander J Blood, Lee-Shing Chang, Shahzad Hassan, et al.
Primary Care Diabetes|February 1, 2024
Methods, rationale, and design for a remote pharmacist and navigator-driven disease management program to improve guideline-directed medical therapy in patients with type 2 diabetes at elevated cardiovascular and/or kidney riskAlexander J Blood, Lee-Shing Chang, Caitlin Colling, et al.
Pageof 71

Showing results (641-650 of 706) with videos related to

Sort By:
Pageof 71
Journal of the American College of Cardiology|January 4, 2011
Ticagrelor versus clopidogrel in patients with acute coronary syndromes undergoing coronary artery bypass surgery: results from the PLATO (Platelet Inhibition and Patient Outcomes) trialClaes Held, Nils Asenblad, Jean Pierre Bassand, et al.
European Heart Journal|September 22, 2018
Modes and timing of death in 66 252 patients with non-ST-segment elevation acute coronary syndromes enrolled in 14 TIMI trialsDavid D Berg, Stephen D Wiviott, Eugene Braunwald, et al.
Diabetes Care|September 25, 2019
Diabetes Is Associated With Worse Long-term Outcomes in Young Adults After Myocardial Infarction: The Partners YOUNG-MI RegistrySanjay Divakaran, Avinainder Singh, David Biery, et al.
Circulation|February 15, 2021
Sex, Permanent Drug Discontinuation, and Study Retention in Clinical Trials: Insights From the TIMI trialsEmily S Lau, Eugene Braunwald, David A Morrow, et al.
American Heart Journal|June 2, 2020
In patients with stable coronary heart disease, low-density lipoprotein-cholesterol levels < 70 mg/dL and glycosylated hemoglobin A1c < 7% are associated with lower major cardiovascular eventsHarvey D White, Ralph A H Stewart, Anthony J Dalby, et al.
Journal of the American College of Cardiology|July 7, 2012
An invasive or conservative strategy in patients with diabetes mellitus and non-ST-segment elevation acute coronary syndromes: a collaborative meta-analysis of randomized trialsMichelle L O'Donoghue, Ajay Vaidya, Rizwan Afsal, et al.
The American Journal of Medicine|May 12, 2020
Comparison of Dabigatran Plus a P2Y<sub>12</sub> Inhibitor With Warfarin-Based Triple Therapy Across Body Mass Index in RE-DUAL PCIRaffaele De Caterina, Antonio Procopio, José-Luis Lopez Sendon, et al.
Journal of the American College of Cardiology|October 27, 2022
Cardiovascular Effects of Canagliflozin in Relation to Renal Function and AlbuminuriaAshish Sarraju, George Bakris, Christopher P Cannon, et al.
Circulation|April 7, 2024
Randomized Evaluation of a Remote Management Program to Improve Guideline-Directed Medical Therapy: The DRIVE TrialAlexander J Blood, Lee-Shing Chang, Shahzad Hassan, et al.
Primary Care Diabetes|February 1, 2024
Methods, rationale, and design for a remote pharmacist and navigator-driven disease management program to improve guideline-directed medical therapy in patients with type 2 diabetes at elevated cardiovascular and/or kidney riskAlexander J Blood, Lee-Shing Chang, Caitlin Colling, et al.
Pageof 71